防腐剂对特布他林雾化液治疗变应性哮喘疗效的影响。
Effect of preservative on the efficacy of terbutaline nebuliser solution in atopic asthma.
作者信息
Lai C K, Chan C H
机构信息
Department of Medicine, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, NT.
出版信息
Thorax. 1993 May;48(5):566-8. doi: 10.1136/thx.48.5.566.
Abstract
The efficacy of bronchodilator nebuliser solutions may be influenced by the presence of preservatives. In a double blind, randomised, crossover study the effect of preservatives in determining the airway responses to 5 mg of terbutaline was studied in a group of 21 atopic asthmatic patients. The presence of preservatives affected neither the bronchodilator action of terbutaline nor its protection against bronchoconstriction induced by histamine.
摘要
支气管扩张剂雾化溶液的疗效可能会受到防腐剂的影响。在一项双盲、随机、交叉研究中，对21名特应性哮喘患者组成的小组进行研究，以探讨防腐剂在确定气道对5毫克特布他林反应中的作用。防腐剂的存在既不影响特布他林的支气管扩张作用，也不影响其对组胺诱导的支气管收缩的防护作用。
相似文献
1
Effect of preservative on the efficacy of terbutaline nebuliser solution in atopic asthma.防腐剂对特布他林雾化液治疗变应性哮喘疗效的影响。
Thorax. 1993 May;48(5):566-8. doi: 10.1136/thx.48.5.566.
2
Paradoxical bronchoconstriction with nebulized albuterol but not with terbutaline.
Am Rev Respir Dis. 1993 Aug;148(2):512-3. doi: 10.1164/ajrccm/148.2.512.
3
Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution.不含防腐剂的异丙托溴铵与爱全乐雾化液疗效比较。
Thorax. 1988 Jun;43(6):446-50. doi: 10.1136/thx.43.6.446.
4
Methacholine challenge tests to demonstrate therapeutic equivalence of terbutaline sulfate via different Turbuhaler devices in patients with mild to moderate asthma: Appraisal of a four-way crossover design.通过不同都保装置对硫酸特布他林在轻至中度哮喘患者中进行治疗等效性的乙酰甲胆碱激发试验：四交叉设计的评估
Pulm Pharmacol Ther. 2017 Jun;44:1-6. doi: 10.1016/j.pupt.2017.02.004. Epub 2017 Feb 20.
5
Comparison of terbutaline and placebo from a pressurised metered dose inhaler and a dry powder inhaler in a subgroup of patients with asthma.在哮喘患者亚组中，比较来自压力定量吸入器和干粉吸入器的特布他林与安慰剂。
Thorax. 1994 Dec;49(12):1228-30. doi: 10.1136/thx.49.12.1228.
6
Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.规律吸入β-受体激动剂治疗期间的支气管扩张剂耐受性和反跳性支气管收缩
Respir Med. 2000 Aug;94(8):767-71. doi: 10.1053/rmed.2000.0820.
7
Effect of terbutaline on hyperpnoea-induced bronchoconstriction and urinary club cell protein 16 in athletes.特布他林对运动员过度通气引起的支气管痉挛和尿 16 型肺表面活性物质相关蛋白的影响。
J Appl Physiol (1985). 2013 Nov;115(10):1450-6. doi: 10.1152/japplphysiol.00716.2013. Epub 2013 Sep 12.
8
A non-bronchoconstrictor, bacteriostatic preservative for nebuliser solutions.一种用于雾化溶液的非支气管收缩性抑菌防腐剂。
Br J Clin Pharmacol. 1991 Feb;31(2):204-6. doi: 10.1111/j.1365-2125.1991.tb05517.x.
9
The bronchodilator response from increasing doses of terbutaline inhaled from a multi-dose powder inhaler (Turbuhaler).
Eur Respir J. 1990 Jan;3(1):24-6.
10
Adenosine monophosphate and histamine induced bronchoconstriction: repeatability and protection by terbutaline.腺苷一磷酸和组胺诱导的支气管收缩：可重复性及特布他林的保护作用
Thorax. 1997 Mar;52(3):239-43. doi: 10.1136/thx.52.3.239.
本文引用的文献
1
Effect of aerosol fenoterol on the severity of bronchial hyperreactivity in patients with asthma.雾化吸入非诺特罗对哮喘患者支气管高反应性严重程度的影响。
Thorax. 1983 Nov;38(11):854-8. doi: 10.1136/thx.38.11.854.
2
A method for comparing the peak intensity and duration of action of aerosolized bronchodilators using bronchoprovocation with methacholine.一种通过用乙酰甲胆碱进行支气管激发试验来比较雾化支气管扩张剂的峰值强度和作用持续时间的方法。
Am Rev Respir Dis. 1984 Jun;129(6):903-6. doi: 10.1164/arrd.1984.129.6.903.
3
Methacholine dose-response curves in normal and asthmatic man: effect of starting conductance and pharmacological antagonism.正常人和哮喘患者的乙酰甲胆碱剂量反应曲线：起始电导和药理学拮抗作用的影响
Clin Sci (Lond). 1984 Jun;66(6):665-73. doi: 10.1042/cs0660665.
4
Adverse reactions to the non-drug constituents of nebuliser solutions.雾化器溶液中非药物成分的不良反应。
Br J Clin Pharmacol. 1988 Mar;25(3):283-7. doi: 10.1111/j.1365-2125.1988.tb03305.x.
5
Use of bronchial provocation with histamine to compare the pharmacodynamics of inhaled albuterol and metaproterenol in patients with asthma.使用组胺进行支气管激发试验以比较吸入用沙丁胺醇和间羟异丙肾上腺素在哮喘患者中的药效学。
J Allergy Clin Immunol. 1987 Jun;79(6):876-82. doi: 10.1016/0091-6749(87)90235-1.
6
Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.沙丁胺醇和异丙托溴铵对哮喘患者气道口径及反应性的剂量相关效应。
Thorax. 1988 Apr;43(4):300-5. doi: 10.1136/thx.43.4.300.
7
Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution.异丙托溴铵（爱全乐）雾化溶液中防腐剂的支气管收缩特性。
Br Med J (Clin Res Ed). 1987 May 9;294(6581):1197-8. doi: 10.1136/bmj.294.6581.1197-a.
8
Effect of 15-(s)-hydroxyeicosatetraenoic acid on allergen-induced asthmatic responses.
Am Rev Respir Dis. 1990 Jun;141(6):1423-7. doi: 10.1164/ajrccm/141.6.1423.
9
A non-bronchoconstrictor, bacteriostatic preservative for nebuliser solutions.一种用于雾化溶液的非支气管收缩性抑菌防腐剂。
Br J Clin Pharmacol. 1991 Feb;31(2):204-6. doi: 10.1111/j.1365-2125.1991.tb05517.x.
Zotero 插件